FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the release of a new series of TaqMan® Gene Signature Panels for accelerating drug discovery research. Researchers who use these gene signature panels, which are offered in low density array formats, will be able to more thoroughly study difficult-to-detect genes that are important to the drug research needs of the pharmaceutical industry.
